SMi releases a quick fire interview with leading ADC expert Dr. Mahendra Deonarain
5th ADC Summit 23-24 May 2016
Chief Scientific Officer of Antikor Biopharma Ltd to speak at the 5th ADC Summit in London in May.
We are seeing more payloads coming through to advanced R&D. These include tubulysins, PBDs, IGNs and more auristatin derivatives. It will be interesting to see how these address the efficacy of ADCs
LONDON, SELECT STATE/PROVINCE, UNI, March 24, 2016 /EINPresswire.com/ -- SMi Group's unrivalled ADC Summit series returns to London on 23rd - 24th May and is proud to have leading industry expert Dr Mahendra Deonarain as key speaker at the conference. Dr. Deonarain will also co-chair the event with Dr Rakesh Dixit, Vice President R&D at MedImmune. — Dr Mahendra Deonarain
In the run up tp the 5th ADC Summit, SMi Group spoke to Dr Mahendra Deonarain about industry developments and his upcoming presentation entitled “Fragment drug conjugates (FDCs): A unique drug class or just smaller ADCs?”. The presentation will also provide insights on drug/linker structures and penetration issues.
When asked which area of ADC is demonstrating the most developments, Dr Deonarain says “From what I can see, we are seeing more payloads coming through to advanced R&D. These include tubulysins, PBDs, IGNs and more auristatin derivatives. It will be interesting to see how these address the efficacy/toxicity balance (therapeutic index).”
The full interview is available to read in the event download centre.
Until 2011, Dr Deonarain was Principle Investigator at Imperial College in Antibody Technology, where he now retains honorary links. He has published over 60 papers/patents in protein/antibody engineering/conjugates. In 2001, he co-founded PhotoBiotics, now a subsidiary of Antikor Biopharma where he is the CSO leading a team to develop the next-generation of antibody-fragment ADCs.
The line-up joining Dr. Deonarain at the 5th ADC Summit include elite international speakers from MedImmune, Takeda, Roche, AstraZeneca, Pfizer, Novartis, Bayer, Merrimack and many more.
For further details or to register, visit the event website at http://www.adcsummit.com/ein. For those who are interested in attending, a £200 early bird saving is currently available online which expires on 31st March.
5th ADC Summit
23-24 May 2016
Holiday Inn Kensington Forum, London UK
http://www.adcsummit.com/ein
--- END ---
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Honey de Gracia
SMi Group Ltd
2078276102
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
